Comprehensive treatment of basal cell carcinoma in nevoid basal cell carcinoma syndrome with 5‐fluorouracil and salicylic acid
- 16 November 2022
- journal article
- letter
- Published by Hindawi Limited in Dermatologic Therapy
- Vol. 35 (12), e15972
- https://doi.org/10.1111/dth.15972
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Combination therapy with 5‐fluorouracil and salicylic acid in a treatment‐resistant case of filiform facial wartsDermatologic Therapy, 2020
- A novel splicing mutation of PTCH1 in a Chinese family with nevoid basal cell carcinoma syndromeMedical Molecular Morphology, 2019
- Use of reflectance confocal microscopy to evaluate 5‐fluorouracil 0.5%/salicylic acid 10% in the field‐directed treatment of subclinical lesions of actinic keratosis: subanalysis of a Phase III, randomized, double‐blind, vehicle‐controlled trialJournal of the European Academy of Dermatology and Venereology, 2017
- Topical 5% 5-fluorouracil in the treatment of multifocal basal cell carcinoma of the face: A novel chemotherapeutic approachOrbit, 2016
- In vivo Reflectance Confocal Microscopy Characterization of Field-Directed 5-Fluorouracil 0.5%/Salicylic Acid 10% in Actinic KeratosisDermatology, 2015
- British Association of Dermatologists' guidelines for the management of cutaneous warts 2014British Journal of Dermatology, 2014
- Emerging medical treatments for actinic keratoses, squamous cell carcinoma and basal cell carcinomaClinical Investigation, 2012
- 5% 5-Fluorouracil Cream for the Treatment of Small Superficial Basal Cell Carcinoma: Efficacy, Tolerability, Cosmetic Outcome, and Patient SatisfactionDermatologic Surgery, 2007